arrow
A

Akira Hamada

kindai university faculty of medicine
H指数:14
被引数:938

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of Methods for Intersegmental Plane Preparation: Supplemental Analysis of JCOG0802/WJOG4607L

各节段平面制备方法的比较:JCOG0802/WJOG4607L的补充分析

2026-09-170
PRE
Safety Profile of Neoadjuvant Chemoimmunotherapy with Nivolumab for Patients with Resectable NSCLC in the Real-world (CReGYT-04 Neo-Venus)

纳武利尤单抗新辅助化免疫疗法在可切除非小细胞肺癌患者中的真实世界安全性分析 (CReGYT-04 Neo-Venus)

2025-10-300
PRE
Impact of the IASLC Grading and Other Pathological Features on Relapse and Survival in Completely Resected Lung Adenocarcinoma by EGFR Mutation Status: A Supplementary Analysis of the CReGYT-01 EGFR Study

IASLC分级及其他病理特征对完全切除的肺腺癌患者复发和生存的影响:按EGFR突变状态分类的CReGYT-01 EGFR研究的补充分析

2025-08-130
PRE
Clinical Utility of the 5-Point Visual Deauville Score for Preoperative Evaluation in Stage I NSCLC: A Multicenter Retrospective Study

5点视觉多维尔评分在术前评估Ⅰ期非小细胞肺癌中的临床应用价值:一项多中心回顾性研究

2025-07-160
PRE
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

Xenium的单细胞空间分析揭示了放疗联合anti-PD-L1治疗后CXCL13 T和CXCL9细胞的抗肿瘤反应

2025-07-160
OA
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
2025-03-010
OA
Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study
2024-04-011
PRE
Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

手术切除的肺癌患者来源的类器官作为生物标志物和药物测试的体外模型的临床相关性

2023-09-014
OA
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial 12119L)
2021-11-0118
PREAI